Literature DB >> 32372183

Painful legs and moving toes syndrome: treating movement to treat pain-a case report.

L Bosco1,2, Y M Falzone1, C Butera2, F Bianchi2, P Vezzulli3, M Filippi4,5,6,7, U Del Carro2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32372183     DOI: 10.1007/s00415-020-09878-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  7 in total

1.  Painful leg moving toes treated with botulinum toxin type A: a video report.

Authors:  Kerrie Schoffer
Journal:  Mov Disord       Date:  2010-04-30       Impact factor: 10.338

Review 2.  Botulinum toxin treatment of pain syndromes -an evidence based review.

Authors:  Yasaman Safarpour; Bahman Jabbari
Journal:  Toxicon       Date:  2018-02-01       Impact factor: 3.033

3.  Treatment of painful limbs/moving extremities with botulinum toxin type A injections.

Authors:  Mahmood Eisa; Carlos Singer; Cenk Sengun; Angela Russel; Bahman Jabbari; Spiridon Papapetropoulos
Journal:  Eur Neurol       Date:  2008-06-14       Impact factor: 1.710

4.  Painful Legs and Moving Toes Syndrome: Putative Underlying Pathophysiology as a Hint for Combined Pharmacological Treatment?

Authors:  Pierluigi Tocco; Stefano Tamburin; Marco Turatti; Matteo Francesco Lauriola; Giampietro Zanette
Journal:  Mov Disord Clin Pract       Date:  2014-10-23

5.  Painful legs and moving toes.

Authors:  J D Spillane; P W Nathan; R E Kelly; C D Marsden
Journal:  Brain       Date:  1971       Impact factor: 13.501

6.  Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection.

Authors:  R L Rosales; K Arimura; S Takenaga; M Osame
Journal:  Muscle Nerve       Date:  1996-04       Impact factor: 3.217

7.  Sustained benefit of painful legs moving toes syndrome with botulinum toxin type A.

Authors:  Ramon L Rodriguez; Hubert H Fernandez
Journal:  J Clin Neurosci       Date:  2013-04-09       Impact factor: 1.961

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.